ListarFP - Artículos por tema "Healthcare costs"
Mostrando ítems 1-1 de 1
-
Cost-effectiveness of omalizumab in severe persistent asthma in Spain: a real-life perspective.
(Taylor & Francis, 2014-11-24)Objectives: To determine the cost-effectiveness of omalizumab compared with routine clinical practice in the treatment and control of severe persistent asthma. Methods: Cost-effectiveness analysis using pre- and ...